Proteinosis alveolar pulmonar: reporte de caso y revisión de la literatura

Alveolar pulmonary proteinosis: case report and literature review

Contenido principal del artículo

Erika Vergara
Oscar Alberto Sáenz
Paulina Ojeda
Andrés López
Camilo Manrique
Francisco Gonzalez
Nicolas Rocha
Rafael Miranda

Resumen

Se describe el caso de una mujer joven con proteinosis alveolar primaria, con cuadro clínico poco frecuente dado la corta duración de la sintomatología, sin factores de riesgo para la entidad, con su evolución clínica y algunas complicaciones relacionadas con el tratamiento. Se realiza además una breve revisión de la literatura sobre la entidad.

Palabras clave:

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Referencias (VER)

Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-42.

Summers Jhon. Pulmonary alveolar proteinosis. Review of the literature with Follow up studies and report of two new cases. California Medicine.Junio 1966: 104.

Huzair I, Kavura S. Alveolar proteinosis syndrome: pathogenesis, diagnosis and management. Curr Opin Pulm Med 2009: 15(5): 491-8.

Ben-Dov I, Kishinevski Y, Roznman J, et al. Pulmonary alveolar proteinosis in Israel:ethnic clustering. Isr Med Assoc J 1999; 1: 75-8.

Seymour J and Presneill J. Pulmonary alveolar proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med 2002; 166.

Nogee LM, de Mello DE DehnerLP. Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328: 406.

Nogee LM, Garnier G, Dietz HC et al. A mutation in the surfactant protein B gene responsible for fatla neonatal respiratory disease in multiple kindreds. J Clin Inves 1994; 93: 1860.

Dirksen U, Nishinakamura R, Groneck P et al. Human pulmonary alveolar proteinosis associated with a defect in GM CSF/IL 3/ IL 5 receptor common beta chain expression. J Clin Inves 1997; 100: 22.

Cordonnier C, Fleury-Feith J, Escudier E,Atassi K, Bernaudin JF. Secondary alveolarproteinosis is a reversible cause of respiratoryfailure in leukemic patients. Am J Respir Crit Care Med 1994; 149: 788-94.

Ladeb S, Fleury-Feith J, Escudier E, Tran Van Nhieu J, Bernaudin JF, Cordonnier C. Secondary alveolar proteinosis in cancer patients.Support Care Cancer 1996; 4: 420-6.

Keller CA, Frost A, Cagle PT, AbrahamJL. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest 1995; 108: 277-80.

Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752-62

Seymour JF, Doyle IR, Nakata K, et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 2003; 58: 252-7

Bonfield TL, ThomassenMJ, Farver CF, et al. Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor. J Immunol 2008; 181:235

Ghio AJ, Stonehuerner JG, Richards JH, et al. Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: a case-control study. Respir Res 2008; 9: 10.

Asamoto H, Kitaichi M, Nishimura K, et al. Primary pulmonary alveolar proteinosis: clinical observation of 68 patients in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33: 835-45.

Fountain FF Jr. Lactate dehydrogenase isoenzymes in alveolar proteinosis. JAMA 1969; 210: 1283.

Wang BM, Stern EJ, Schmidt RA, PiersonDJ. Diagnosing pulmonary alveolar proteinosis: a review and an update. Chest 1997; 111: 460-6.

Lee KN, Levin DL, Webb WR, Chen D,Storto ML, Golden JA. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic,and functional correlations. Chest 1997; 111: 989- 95.

Johkoh T, Itoh H, Muller NL, et al. Crazy-paving appearance at thin-section CT:spectrum of disease and pathologic findings. Radiology 1999; 211:1 55-60

Kitamura T, Uchida K, Tanaka N, et al.Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162: 658-62

Ramirez J, Kieffer RF Jr, Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med 1965; 63: 819-28.

Ramirez J. Bronchopulmonary lavage. New techniques and observations. Dis Chest 1966; 50: 581-8.

Rogers RM, Tantum KR. Bronchopulmonary lavage. A ‘new’ approach to old problems. Med Clin North Am 1970; 54: 755-71.

Rogers RM, Levin DC, Gray BA, et al. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978; 118: 255-64

Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquiredalveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-31

Witty LA, Tapson VF, Piantadosi CA. Isolation of Mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore) 1994; 73: 103-9.

Uchida K, Beck D, et al. GM CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis. N Eng J Med 2007; 356: 567

Citado por